Reimbursement

The ranks of Medicaid keep growing, and at record levels. But while that's good news for hospital systems' uncompensated care budgets, there are still challenges.

The stakes for improvement and innovation are high in American cancer care, and insurers are trying to wield some of their influence to get a return on investment for their members and their budgets.

The Affordable Care Act's rate review is turning out well for consumers, according to the federal government, and although insurers may not be stoked about the new administrative work, it doesn't seem to be scaring them away.

A shrinking number of Medicare Part D drug plans is set to bring beneficiaries some more low-cost choices, but also some potentially confusing benefit designs.

Federal trade regulators have proven their willingness to go after hospital consolidation. Now, they're raising some new concerns about an up-and-coming insurer strategy.

With enrollment at an all-time high and only increasing, state Medicaid programs and the health plans they contract with need to prioritize a few key areas of the beneficiary experience.

With the latest NCQA rankings come fresh marketing material and customer satisfaction bona fides, although that doesn't always inoculate them from having to explain coverage controversies in the media.

In terms of enrollment, which two states have the least successful health insurance exchanges? The ones where the largest insurer is setting out a key segment of the new market.

Restricting access to prestigious, long-available providers can sometimes cost insurers long-held contracts and be competitive gains for others.

A program that combines a mobile app, analytics and direct intervention is showing promise in reducing the costs associated with hospitals' most expensive patients -- the so-called "super-utilizers."